TherapeuticsMD Q2 EPS $0.01 Down From $0.05 YoY, Sales $869.000K Down From $952.000K YoY

TherapeuticsMD (NASDAQ: TXMD ) reported quarterly earnings of $0.01 per share. This is a 80 percent decrease over earnings of $0.05 per share from the same period last year. The company reported $869.000 thousand in sales this quarter. This is a 8.72 percent decrease over sales of $952.000 thousand the same period last year.